Program Areas
Quick Reference
Home » Training »
In the fall of 2018, EPA finalized tailored and streamlined standards for managing hazardous waste pharmaceuticals that reduce the cost and compliance burden for the healthcare sector, while ensuring the safe management of hazardous waste pharmaceuticals. These changes provide regulatory certainty and national consistency on how the Resource Conservation and Recovery Act (RCRA) applies to the reverse distribution of prescription pharmaceuticals while incorporating flexibilities to accommodate current business practices. With this rule EPA is also taking a common-sense regulatory approach to the disposal of Food and Drug Administration (FDA)-approved, over-the-counter nicotine replacement therapies (i.e., patches, gums and lozenges), which will no longer be considered hazardous waste when discarded.

There are no attachments.

Related Items
There are no related items.


Last Updated: July 31, 2017